Dr. Ann E. Stapleton, MD

Dr. Stapleton practices at Eisenhower Medical Center - Behavioral Health Rimrock - HOPD in Palm Springs, California.

Dr. Stapleton's NPI, 1851477582, was assigned on October 27, 2006. Dr. Stapleton graduated from Albert Einstein College of Medicine in 1984. Dr. Stapleton holds California license G57133.

Dr. Stapleton's primary practice is Eisenhower Medical Center - Behavioral Health Rimrock - HOPD, at 4791 E Palm Canyon Dr, Palm Springs, CA 92264.

Dr. Stapleton's primary practice is Eisenhower Medical Center - Behavioral Health Rimrock - HOPD in Palm Springs, California. Dr. Stapleton is also affiliated with Eisenhower Health. The medical group on file is Eisenhower Health. Dmand AI also links Dr. Stapleton to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stapleton practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Stapleton's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Stapleton is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Stapleton's licenses on file in 2 states: California and Washington.

Dmand AI lists acute mini-stroke (TIA), acute sinusitis, arthritis, bladder disease, cardiomyopathy, chronic diabetes, chronic hypertension and chronic lung disease among the conditions Dr. Stapleton treats.

CMS data shows 878 Medicare services from Dr. Stapleton across 8 procedure codes in 2024, for 315 Medicare patients. Medicare paid $59,250 for them.

CMS counts 315 Medicare patients who saw Dr. Stapleton in 2026. The largest group is 65 to 74, with 160 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stapleton's median patient age at 71, with 14% women.

In 2026, Dr. Stapleton wrote 9,673 Medicare Part D claims for 539 patients. 64% of them were for generic drugs. CMS names the drug for 8,842 of them, across 141 drugs with 11 or more claims each, at $11,896,117 in total drug cost. In 2023, CMS named 8,821 claims across 150 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Stapleton for performance year 2026, reported as part of a group. Dr. Stapleton accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stapleton as offering telehealth.

Dmand AI links 94 papers to Dr. Stapleton, published from 2000 to 2025. 2020 was the busiest year, with 9. The most frequent topics are Escherichia coli, Urinary Tract Infections and Escherichia coli Infections. Dr. Stapleton has published most often in J Infect Dis. Dr. Stapleton's most frequent co-authors are Thomas M. Hooton, MD, Linda Brubaker, MD and Alayne D. Markland.

Dmand AI links Dr. Stapleton to 4 clinical trials. Conditions studied include Urinary Tract Infections, Urologic Diseases and Cystitis. University of Washington sponsors the most, 4.

CMS Open Payments shows 53 general payments to Dr. Stapleton from 10 drug and device companies from 2017 to 2024. Consulting fees make up the largest share, 68% of the total. GlaxoSmithKline, LLC. paid the most, $18,936. It also lists 12 research payments totaling $856 in 2019.

Dmand AI lists 6 awards for Dr. Stapleton, most recently Fellow in 2008.

Dr. Stapleton graduated from Albert Einstein College of Medicine in 1984. Dr. Stapleton is a member of ACP, AUA and IDSA.

Dr. Stapleton is in network with 14 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Aetna. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.